Table 4 The asthma treatment used by the patients in both cohorts and each of three phenotypes of the discovery and validation cohort.
From: Data-driven questionnaire-based cluster analysis of asthma in Swedish adults
Medication % | Discovery cohort | Validation cohort | ||||
|---|---|---|---|---|---|---|
Early onset predominantly female | Adult onset predominantly female | Adult onset predominantly male | Early onset predominantly female | Adult onset predominantly female | Adult onset predominantly male | |
No ICS | 38.0 | 45.7 | 52.8 | 40.5 | 46.4 | 53.6 |
Only ICS | 18.3 | 16.8 | 14.6 | 11.0 | 16.2 | 15.3 |
ICS and (LABA and/or LTRA) | 43.7 | 37.5 | 32.6 | 48.5 | 37.5 | 31.1 |
